Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2010
08/19/2010US20100209421 Targeting pax2 for the treatment of breast cancer
08/19/2010US20100209420 Methods of treating cancer using pyridopyrimidinone inhibitors of p13k alpha
08/19/2010US20100209419 Method and formulation for treating adverse biological conditions
08/19/2010US20100209418 Solid Forms of a Raf Kinase Inhibitor
08/19/2010US20100209417 Antibody Treatment of Alzheimer's and Related Diseases
08/19/2010US20100209416 Immunoassays for lamotrigine
08/19/2010US20100209415 Chemotherapeutic methods and compositions
08/19/2010US20100209414 Methods and Compositions Related to Cyclic Peptide Synthesis
08/19/2010US20100209409 Method for suppressing immune system response to transplanted tissue or cells
08/19/2010US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function
08/19/2010US20100209389 Multi-Compartmented Container
08/19/2010US20100209386 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
08/19/2010US20100209384 Sustained release formulations comprising very low molecular weight polymers
08/19/2010US20100209357 Localized Therapy of Lower Airways Inflammatory Disorders with Proinflammatory Cytokine Inhibitors
08/19/2010US20100209346 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
08/19/2010US20100209342 Apcdd1 inhibitors for treating, diagnosing or detecting cancer
08/19/2010US20100209341 Treatment of chronic inflammatory conditions
08/19/2010US20100209340 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
08/19/2010CA2752205A1 Influenza hemagglutinin and neuraminidase variants
08/19/2010CA2752136A1 Anti-mst1r antibodies and uses thereof
08/19/2010CA2752041A1 Influenza vaccines with increased amounts of h3 antigen
08/19/2010CA2752039A1 Influenza vaccine regimens for pandemic-associated strains
08/19/2010CA2752033A1 Antibody to cytolethal distending toxin of campylobacter jejuni
08/19/2010CA2751379A1 Influenza vaccines with reduced amounts of squalene
08/19/2010CA2726230A1 The stabilisation of proteins
08/18/2010EP2218782A2 Anti-OX40L Antibodies
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218733A1 Compounds and methods for treatment and diagnosis of chlamydial infection
08/18/2010EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218730A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218461A1 CD40 antibody formulation and methods
08/18/2010EP2218460A2 Quality control methods for oil-in-water emulsions containing squalene
08/18/2010EP2217699A2 Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres
08/18/2010EP2217626A1 Epitope for neutralizing antibodies
08/18/2010EP2217617A1 Compositions for detecting antibodies to babesia microti and methods of uses thereof
08/18/2010EP2217272A1 Immunotherapeutic method for increasing groundnut tolerance in a subject
08/18/2010EP2217271A1 Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine
08/18/2010EP2217270A1 Antigen-antibody complexes as hiv-1 vaccines
08/18/2010EP2217269A2 Vaccine nanotechnology
08/18/2010EP2217268A2 Anti-human il-21 monoclonal antibodies
08/18/2010EP2217249A1 Inhibition of versican with sirna and other molecules
08/18/2010EP2217222A1 Method and compositions for cutaneous immunisation
08/18/2010EP1767633B1 Novel polypeptide useful for diagnosis and treatment of cancer
08/18/2010EP1636352B1 Improvements in virus production
08/18/2010EP1597275B1 Use of the Chlamydia pneumoniae CPn0104 polypeptide or antibodies thereto to diagnose Chlamydia infections
08/18/2010EP1307222B1 Non-human animal models of tolerance to hepatitis c virus immunogens
08/18/2010EP0723402B1 Senescent cell-derived inhibitors of dna synthesis
08/18/2010CN101809162A anti-glypican-3 antibody having improved kinetics in plasma
08/18/2010CN101809148A Novel immunotherapy against neuronal and brain tumors
08/18/2010CN101809144A Method for producing flu virus
08/18/2010CN101809037A Human antibodies to human cd20 and method of using thereof
08/18/2010CN101809036A Fixed single injection dosage for ocrelizumab (2H7)
08/18/2010CN101809035A Antigen binding proteins capable of binding thymic stromal lymphopoietin
08/18/2010CN101809034A C3b antibodies and methods for the prevention and treatment of complement- associated disorders
08/18/2010CN101809033A Antibody having inhibitory activity on infection with hepatitis c virus (HCV), and use thereof
08/18/2010CN101808664A Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same
08/18/2010CN101808663A anti-rsv g protein antibodies
08/18/2010CN101808662A Composition and method for treatment of autoimmune disease
08/18/2010CN101808661A anti-ige antibodies
08/18/2010CN101808660A Vaccine peptide combinations against cat allergy
08/18/2010CN101808659A Inactivated influenza vaccine
08/18/2010CN101808658A Cell-penetrating peptides and use thereof bonded to biomolecules with therapeutic action
08/18/2010CN101808657A Stabilization of vaccines by lyophilization
08/18/2010CN101808656A Vaccine for the treatment of osteoarthritis
08/18/2010CN101805723A Anti-glutamate dehydrogenase protein monoclonal antibody, preparation method thereof and use thereof
08/18/2010CN101805408A Antitumor and thrombolytic double-effect chimeric protein, preparation method thereof and use thereof
08/18/2010CN101805393A REPLIKIN peptides and uses thereof
08/18/2010CN101804213A Methods and compositions for detection and diagnosis of infectious diseases
08/18/2010CN101804205A Use of VEGF antibody and VEGF receptor antagonist in preparation of pain-killing vaccine or medicament
08/18/2010CN101804203A Method for mass production of pseudorabies virus vaccine
08/18/2010CN101804202A Methods of producing influenza vaccine compositions
08/18/2010CN101804201A Method for preparing high-purity Japanese encephalitis purified vaccine by using bioreactor
08/18/2010CN101804200A Broad spectrum anti-viral therapeutics and prophylaxis
08/18/2010CN101235363B Pig transmissible gastroenteritis virus vaccine strain and application thereof
08/18/2010CN101168743B Recombination baculoviral and its preparation method and application
08/18/2010CN101085348B Nasal cavity immunity composite adjuvant for avian influenza inactivation antigen
08/18/2010CN101024076B Novel use of coccidium
08/17/2010US7777020 Nucleotide sequences derived from the env gene of HIV-1
08/17/2010US7777019 nucleic acid encoding the antibodies conjugated to radioisotope, drug, cytotoxic agent or biodrug; immunotoxin of use to treat cancer; immunoassay kit for detection of CD 22+ cancer cells; lymphoma
08/17/2010US7777018 CDR-grafted anti-tissue factor antibodies and methods of use thereof
08/17/2010US7777017 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo
08/17/2010US7777011 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy
08/17/2010US7777010 Recovering preferential protein from library; obtain genetically engineered cells, transform with vector coding preferential protein, express protein, isolate protein
08/17/2010US7777009 for modulation of chemokines; antiinflammatory agents; cancer
08/17/2010US7777008 ILT3 binding molecules and uses therefor
08/17/2010US7776834 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides
08/17/2010US7776824 neutrophil gelatinase-associated lipocalin (NGAL); siderophore coadministration to enhance secretion
08/17/2010US7776822 native staphylococcal enterotoxin or streptococcal pyrogenic exotoxin protein, stimulates T cell mitogensis; fusion proteins; carcinomas; combination therapy
08/17/2010US7776817 coadministering tissue plasminogen activator, serum albumin, antidote, anticonvulsant; for damage caused by stroke, inflammation or organophosphate neurotoxins
08/17/2010US7776814 with cyclodextrins, polyoxyethylene glycol; anticancer agents
08/17/2010US7776620 Hapten-carrier conjugates for treating and preventing nicotine addiction
08/17/2010US7776552 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
08/17/2010US7776548 Endocytotic pathway delivery vehicle for targeting drugs and antibodies to prostate and other tissues
08/17/2010US7776546 Using immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics
08/17/2010US7776541 Psoriasin expression by breast epithelial cells
08/17/2010US7776540 Method of treating skin inflammation
08/17/2010US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH)
08/17/2010US7776343 comprising a negatively charged organic carrier and a positively charged antigen; for facilitating the induction of a cytotoxic T-lymphocyte response to an antigen
08/17/2010US7776342 Preparations that potentiate immunogenicity in low immunogenic antigens
1 ... 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 ... 1823